Can a website help women decide on breast cancer screening?
NCT ID NCT05607849
First seen Sep 25, 2026 · Last updated Sep 25, 2026
Summary
This French trial tests whether a decision aid leaflet and website help women make informed choices about organized breast cancer screening. It includes women aged 50 to 74 who are invited for screening and their general practitioners. Researchers measure decisional conflict and intention to participate two months after women receive the tool.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- a decision aid leaflet and website about breast cancer screening
- What this could lead to
- If it works, this could give women clearer information and more confidence when deciding whether to join breast cancer screening.
- What could go wrong
- The tool may not change how women decide, and the results may not apply outside France. The study does not test whether screening itself saves lives.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
20,000 people
The number who actually took part.
- Started
-
Apr 2025
- Finished
-
Sep 2025
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
50 to 74 years
- Sex
-
Female participants only
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria : \- General practitioners (GPs): The following GPs will be included: 1\) Practicing in one of the French départements (administrative area) covered by the study. \- Women: The following women will be included: 1. Invited to participate in OBCS by the National Health Insurance Agency (Caisse Nationale d'Assurance Maladie; CNAM) during the studied month: eligible for OBCS, therefore aged between 50 and 74 at the time of inclusion; 2. On the patient list of a GP who is covered by the study at the time of inclusion; 3. Covered by one of the CPAM (Caisse Primaire d'Assurance Maladie) in the participating departments. Exclusion Criteria : \- General practitioners (GPs) : The following GPs will be excluded: 1. Those who do not have any patients invited for OBCS in the studied month; 2. Those whose practice does not correspond to the usual activities of a GP (known as a Mode d'Exercice Particulier), or who have very few patients (who have seen fewer than 100 different patients in the year preceding the experiment); 3. Those who practice within a health centre (as it is impossible to evaluate the activity of an individual practitioner in health insurance databases); 4. Those who explicitly state that they do not want to take part in the study, in response to an initial letter of invitation. This letter will inform them that the study is being run, and will inform them of the option to refuse to participate if they so wish; 5. Those who are participating in the MyPEBS study (the only national study of OBCS at the time the present protocol was drawn up). * Women: The following women will not be included: 1. Participants in the MyPEBS study ( the only national study of OBCS at the time the present protocol was drawn up); or, 2. If their GP refuses to participate in the study; or, 3. women under guardianship. The following women will be excluded: * Those who object to the study in accordance with regulatory procedures issued by the Data Protection Officer (DPO), * Those who do not respond within 1 month after the questionnaire has been sent.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Breast cancer are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
University Hospital
Nantes, 44093, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Broccoli vs hot flashes: diet put to the test in breast cancer survivors
- Can a Nurse-Led, App-Based Follow-Up ease life after breast cancer?
- Can a tailored exercise program boost motivation and Well-Being during breast cancer treatment?
- AI trained to spot hidden clues in breast cancer slides
- Can a nerve block calm inflammation after breast cancer surgery?
- Can a STAT3 pill break breast Cancer's resistance to standard treatment?